Oncology & Cancer
Scientists advance findings about novel, low-toxicity anticancer agent
(Medical Xpress)—Researchers at Roswell Park Cancer Institute (RPCI) have found that a new formulation of a promising anticancer agent, the small chemical molecule FL118, is even more effective in controlling two types ...
Apr 3, 2013
0
0